392 related articles for article (PubMed ID: 17115983)
1. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
2. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
5. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
6. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
7. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
Bussone G; Diener HC; Pfeil J; Schwalen S
Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
[TBL] [Abstract][Full Text] [Related]
8. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
9. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
11. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
12. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
13. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
14. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
15. The impact of topiramate on health-related quality of life indicators in chronic migraine.
Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
[TBL] [Abstract][Full Text] [Related]
16. Topiramate: new indication. Migraine prevention: best avoided.
Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
[TBL] [Abstract][Full Text] [Related]
18. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
Mei D; Capuano A; Vollono C; Evangelista M; Ferraro D; Tonali P; Di Trapani G
Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
[TBL] [Abstract][Full Text] [Related]
20. Topiramate in migraine prevention.
Silberstein SD
Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
